Neurology and movement disorders
Clinical research activity includes Parkinson’s disease, with interest in symptoms and disease mechanisms linked to neurodegeneration and motor dysfunction.
- Parkinson’s disease
- Neurodegenerative disorders
- Motor symptom management
Work in this area reflects a focus on brain-related conditions where neurological function and progression of disease are central therapeutic concerns.
Inflammatory and autoinflammatory diseases
Research also covers cryopyrin-associated periodic syndrome, a rare autoinflammatory disorder associated with recurrent systemic inflammation.
- Cryopyrin-associated periodic syndrome
- Autoinflammatory disease
- Systemic inflammation
This therapeutic area centers on conditions driven by abnormal immune activation and inflammatory pathways.
Central nervous system therapeutics
The sponsor’s portfolio includes compounds intended for brain disorders, with relevance to Alzheimer’s disease and related central nervous system indications.
- Brain disorders
- Alzheimer’s disease
- Central nervous system disorders
These interests point to therapeutic development in conditions affecting cognition, neurological integrity, and brain function.
Translational pharmacology
Clinical activity spans early human evaluation of novel compounds in both healthy volunteers and patients with neurological disease, supporting interest in drug absorption, elimination, and overall pharmacokinetics.
- Healthy volunteer studies
- Pharmacokinetics
- Neurological drug development
The research landscape combines human safety assessment with therapeutic exploration in disorders of the brain and immune system.
